Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France
Authors not listed
University Hospital, Brest · 2018
Abstract
Neuroendocrine cancer remains a poorly known entity. Comprehensive treatment is multidisciplinary involving surgery, radiological and nuclear medicine, and medical. A national network for the management of sporadic and hereditary malignant neuro-ENdocrine Tumor (RENATEN) is in charged of coordinating this specific care. This is part of the French National Cancer INstitute (INCa) Rare Cancer Plan.
The project is in the form of an analysis of elderly population (75 years or over) with a diagnosis of neuroendocrine cancer in the western part of the France (Brittany, Pays de Loire, Normandy, Center and a part of New Aquitaine areas) representing a population of more than 12 millions of inhabitants. Oncogeriatric evaluations, specialized meetings, ...would be analysed in order to improve the care of rare cancer patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2018). Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France. <em>University Hospital, Brest</em>. https://clinicaltrials.gov/study/NCT03749681
Vancouver
Anonymous. Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France. University Hospital, Brest. 2018.
BibTeX
@misc{anon2018Neuroe,
title = {Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France},
author = {Anonymous},
journal = {University Hospital, Brest},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Zealand University Hospital 2023
Open access · US-GOV
Organ SPARring Surgery vs. Standard Resection for Early Stage COLon Cancer in Elderly Frail Patients
Hospices Civils de Lyon 2020
Open access · US-GOV
Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis
Interdisciplinary topics in gerontology and geriatrics 2013
Citation only
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging, or Vice Versa?
Cancer Medicine 2023
Open access · CC-BY
Association between PD ‐1 inhibitor‐related adverse events and frailty assessed by frailty index in lung cancer patients
University Hospital, Strasbourg, France 2024
Open access · US-GOV
Geriatric Assessment at Discharge From the Intensive Care Unit in Patients Aged 75 Years and Older: a Feasibility Study
Frontiers in Oncology 2019
Open access · CC-BY